Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

N/AUnknownNCT01148407

University of Vermont30 enrolled

Overview

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a diagnosis of malignancy Exclusion Criteria: * Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy

Locations (1)

University of Vermont/Fletcher Allen Health Care

Burlington, Vermont, United States

RECRUITING

Central Contacts

Chris E Holmes, MD, PhD

CONTACT

802-656-0302 ceholmes@uvm.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.